FDA approval of a generic ramelteon formulation; this is a regulatory action, not a clinical evidence trial, and does not report efficacy or safety data.
Reported
Approved dose strength8 mg
Approval date2026-06-04
Loading
Drug or technology
1 development in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
FDA approval of a generic ramelteon formulation; this is a regulatory action, not a clinical evidence trial, and does not report efficacy or safety data.